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Experimental procedures for ADME and PK studies S2-S5 Additional synthetic schemes Schemes S1-S6 Additional synthetic procedures and compound characterization S7-S9 KinomeScan analysis for compound 1 Table S1 FLT3 and MV4-11 data with confidence intervals Table S6 side on the same plate. 175 µL of each well was dispensed from the master plate into five storage plates. For 0 h time point, 450 µL of pre-cooled (4 ºC) internal standard (10 µM warfarin in methanol) was added to the first plate before the reaction started. 5.25 mL of microsome assay solution A (Fisher Scientific, catalog #NC9255727) was combined with 1.05 mL of solution B (Fisher Scientific, catalog #NC9016235) in 14.7 mL of potassium phosphate buffer (0.1 M, pH 7.4). 45 µL of this A+B solution was added to each well of all the 96-well storage plates and mixed briefly with pipette. The plates were sealed, and all plates except the 0 h plate were incubated at 37 ºC, with shaking at 60 rpm. 0.5 h, 1 h, 2 h, and 4 h time points were taken. At each time point, 450 µL of pre-cooled internal standard was added to quench the reaction. The quenched plate was then centrifuged (model 5810R, Eppendorf, Westbury, NY) at 4000 rpm for 15 min. 150 µL of supernatant was transferred to a 96-well plate and analyzed by UPLC-MS. The compounds and internal standard were detected by SIR. The log peak area ratio (compound peak area / internal standard peak area) was plotted vs. time (h), and the slope was determined to calculate the elimination rate constant [k = (-2.303) * slope]. The half-life (h) was calculated as t 1/2 = 0.693 / k. Intrinsic clearance was calculated as CL int = (0.693 / (t 1/2 ) * (1 / microsomal concentration in the reaction solution) * (45 mg microsome / g liver) * (g liver / kg b.w.), where microsomal concentration in the reaction solution is 0.5 mg/mL, and g liver / kg b.w. of CD-1 female mice and human are 52 and 20, respectively.
Caco-2 and MDR1-MDCKII permeability assay. High throughput Caco-2 and MDR1-MDCKII permeability was performed in the Transwell® 0.4 µm polycarbonate membrane 96-well system with modified methods. 1, 2 Caco-2 and MDR1-MDCKII cells were maintained at 37 °C in a humidified incubator with an atmosphere of 5% CO 2 . The cells were cultured in 75 cm 2 flasks with Dulbecco's Modified Eagle's Medium (DMEM) containing 10% fetal bovine serum (FBS), 1% non-essential amino acids (NEAA), 100 units/ml of penicillin, and 100 µg/ml of streptomycin. The Caco-2 and MDR1-MDCKII cells were seeded onto inserts at a density of 2×10 4 and 1×10 4 cells/insert separately. The medium in the wells was exchanged each other day, and the trans epithelial electrical resistance (TEER) value was measured using an epithelial voltohm meter (Millipore, Billerica, Massachusetts). Caco2 cells were grown for 7 days and MDR1-MDCKII cells were grown for 4 days to reach consistent TEER values (typically 2000 ohms greater than initial value when cells are first seeded into transwells), indicating that the cells had formed a confluent polarized monolayer.
For transport experiments, each cultured monolayer on the 96-well plate was washed twice with a transport buffer (HBSS/25 mM HEPES, pH 7.4). The permeability assay was initiated by the addition of each compound solution (10 µmol/L) into inserts (apical side, A) or receivers (basolateral side, B). The Caco-2 cell monolayers were incubated for 2 h at 37 °C and the MDR1-MDCKII cell monolayers were incubated for 1 hour at 37 °C. Fractions were collected from receivers (if apical to basal permeability) or inserts (if basal to apical permeability), and concentrations were assessed by UPLC/MS (Waters; Milford, MA). All compounds were tested in triplicates.
The A→B (or B→A) apparent permeability coefficients (Papp) of each compound were calculated using the equation, Papp=dQ/dt×1/AC 0, where dQ/dt equals the flux of a drug across the monolayer, A equals the total insert well surface area, and C 0 is the initial concentration of substrate in the donor compartment. The efflux ratio was determined by dividing the P app in the S5 B-A direction by the P app in the A-B direction. An efflux ratio >2 suggested that a given substrate was actively transported across the membrane.
Maximum tolerated dose (MTD) study in mice. During the acute observation phase after dosing, no adverse reactions or compound-related side effects were observed based on based on a functional observational battery. All animals maintained normal feeding behavior and body weight during the 48 h period following i.p. administration of compound at all doses. No significant changes to hematological parameters, clinical chemistries, or gross organ anatomy were observed at the terminal point of the study. However, previous pilot study suggested rapid neurotic/cardiac driven toxicity at 50 mg/kg, and a plunge of plasma glucose levels were observed within 30 minutes post injection (data not shown). The blood work of compound 5e after IP dosing is summarized in Table S6 .
PK analysis was conducted on an AB Sciex 6500 coupled to Waters Acquity UPLC (LC/MS/MS) using positive electrospray ionization multiple reaction monitoring (MRM) mode. An Acquity BEH C18, 1.7 µM, 2.1*50 mm column with acetonitrile (B) -water (A) gradient containing 0.1% formic acid as mobile phase. LC conditions were a gradient (98-20% A), cycle time, 2 min. using an injection volume of 2.5 µL and flow rate of 0.6 mL/min. The calibration curve was obtained as follows: The calibration was done using the same biological matrices to ensure the similar recovery. Serial dilution (1:2) of compound stock solution (in DMSO) was spiked into 99 volumes of blank mouse plasma (final concentration from 13.7 to 3333 nM). 1 volume of spiked plasma was combined with 3 volumes of internal standard (2 µM warfarin in acetonitrile) to precipitate the mouse plasma proteins. all concentrations in the calibration range must be no more than 20% deviation. If there were any points with more than 20% deviation on the high or low end, the calibration range would be truncated. If an outlier occurred in the middle of the curve, the whole curve would be re-done. The signal: noise of the compound peak at the LLOQ must be greater than 5. Partial validation is achieved if >75% duplicated calibrations, >2/3rd of total QCs, >50% QC from each level, meet acceptance interval <20% for LLOQ, 15% for other levels. The samples are tested on the same or second day and another set of QC ran immediately after sample analysis. Additional synthetic procedures and compound characterization.
N-Methyl-3-(pyridin-3-yl)aniline (24).
A mixture of 3-bromo-N-methylaniline (1.0 mmol, 1.0 eq.), pyridin-3-ylboronic acid (1.2 mmol, 1.2 eq.), potassium carbonate (3.0 mmol, 3.0 eq.), and Pd(Ph 3 ) 4 (0.050 mmol, 5 mol%) in 2.0 mL (0.50M) dioxane/water (3:1) was degassed then stirred in a nitrogen atmosphere at 80 °C for 16 h. After cooling to room temperature the reaction mixture was partitioned between ethyl acetate (3 mL) and water (2 mL). The aqueous phase was extracted into ethyl acetate (3 x 3 mL). The combined organics were dried over magnesium sulfate, filtered, and concentrated. Purification using automated flash chromatography (EtOAc/hexanes) was followed by evaporation giving 24 as a yellow oil (0.150 g, 81% 
3-(Pyridin-3-yl)phenol (25).
A mixture of 3-bromophenol (1.0 mmol, 1.0 eq.), pyridin-3-ylboronic acid (1.1 mmol, 1.1 eq.) potassium carbonate (3.0 mmol, 3.0 eq.), and Pd(Ph 3 ) 4 (0.050 mmol, 5 mol%) in 2.0 mL (0.50M) of dioxane/water (3:1) was degassed then stirred at 80 °C in a nitrogen atmosphere. After 16 h, the reaction mixture was cooled to room temperature and diluted with water (3 mL). The reaction mixture was then extracted into ethyl acetate (3 x 3 mL).
S8
The combined organics were washed with saturated sodium bicarbonate solution (5mL) followed by brine (5mL). The organic phase was dried over magnesium sulfate, filtered, and concentrated. Purification using automated flash chromatography (EtOAc/hexanes) was followed by evaporation giving 25 as a white solid (0.119 g, 70% h, the reaction mixture was cooled to room temperature. Saturated sodium bicarbonate (5 mL) was added to the reaction mixture and extracted into ethyl acetate (3 x 10 mL). The combined organics were washed with brine (20 mL), then dried the organic phase over magnesium sulfate, filtered and concentrated. Purification using automated flash chromatography (EtOAc/hexanes) was followed by evaporation giving 31 as a yellow oil (0.131 g, 75% 
3-(Pyridin-3-yl)cyclohexan-1-one (31)
.
3-(Pyridin-3-yl)cyclohexan-1-amine (32).
A mixture of 31 (0.28 mmol, 1.0 eq.), titanium (IV) isopropoxide (0.56 mmol, 2.0 eq.), ammonium chloride (0.56 mmol, 2.0 eq.), and triethylamine (0.56 mmol, 2.0 eq.) were stirred at room temperature in EtOH (2.0 mL, 0.19M) in a nitrogen atmosphere for 16 h. Sodium borohydride (0.57 mmol, 1.5 eq.) was then added and the reaciton mixture was allowed to stir at room temperature for an additional 7 h. The reaction was then quenched with saturated sodium bicarbonated solution (2 mL) and extracted into ethyl acetate (3 x 5 mL). A thick paste formed and the ethyl acetate was decanted, then washed with brine, dried organic phase over magnesium sulfate, filtered and concentrated. Purification using automated flash chromatography (MeOH/DCM) was followed by evaporation giving 32 as a yellow oil (0.019 g, 29% 30  SRPK2  100  SRPK3  55  STK16  42  STK33  44  STK35  86  STK36  49  STK39  97  SYK  16  TAK1  19  TAOK1  97  TAOK2  94  TAOK3  98  TBK1  62  TEC  94  TESK1  77  TGFBR1  75  TGFBR2  30  TIE1  17  TIE2  38  TLK1  100  TLK2  100  TNIK  33  TNK1  40   S22   TNK2  43  TNNI3K  95  TRKA  5.3  TRKB  16  TRKC  27  TRPM6  97  TSSK1B  60  TSSK3  86  TTK 9.1788 7.9173-10.6414
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